Rosie Bradbury

Venture Capital Reporter

Rosie Bradbury is a reporter covering startups and venture capital for PitchBook News. Based in New York, she previously reported for the Bureau of Investigative Journalism, Business Insider and Wired. Rosie studied history and politics at the University of Cambridge.


Bumper profits for oil and gas yield spare cash for moonshot climate-tech bets

Oil and gas corporations have more spare cash than ever to throw at commercially untested early-stage climate technologies.

3 charts: The US has more startups than VCs can support

There are still over 55,000 solvent VC-backed companies in the US, many of which are aggressively competing for funding.

Sky-high AI engineer salaries are complicating startups’ equity playbook

Even with less cash and fighting power than corporates, startups are staying competitive in the fray.

VC fund returns uptick signals sunnier skies in 2024

VCs tend to mark their portfolio holdings based on comparable public stocks, which saw a revival in the latter half of 2023.

Is the ridehailing startup dead? BlaBlaCar’s 43% markup says not

Swedish VC firm VNV Global has marked up its stake in mobility startup BlaBlaCar, citing 20-25% active user growth in 2023

IPO Watchlist: The biopharma unicorns that could go public in 2024

Since January, eight biopharma companies have already gone public. PitchBook’s Exit Predictor projects which unicorns could be next.

Nvidia, Microsoft rain on AI-driven IPO parade

The Astera Labs’ IPO was a welcome signal for AI investors, but it was overshadowed by big swings from Microsoft and Nvidia that suggest a shakeout is coming.

Reddit’s $6.4B IPO ranks near the top of Sam Altman’s angel wins

The social media company priced its IPO Wednesday at $34 per share, signaling investor confidence in the face of a turbulent exit market.

Meet the nuclear fusion startups with the deepest pockets

The success of companies like Helion and Commonwealth Fusion Systems have paved the way for cleantech’s moonshot project.

Early-stage startups seeking venture debt find investor prestige isn’t enough

Securing venture debt is a challenge even for founders with name-brand backers as lenders get more aggressive on due diligence.

Lance Armstrong’s Next Ventures targets $100M 2nd fund

Prominent athletes are ramping up their investments in the private markets.

Early-stage SaaS boasts best expected exit success rate for VCs

Enterprise SaaS has been the tried-and-true winner for VC returns for years, and PitchBook research suggests that’s unlikely to change any time soon

Market Map: Drones and robots pull VCs back to agtech

Despite a wider retreat from agtech, precision ag technology has proven that it can weather a challenged VC environment.

Vertical farming startup cinches $134M for designer fruit, defying agtech winter

Oishii’s fresh round is a rare success during a brutal few years for vertical farming startups.

The business of winding down startups is booming

From digital media startup The Messenger to “Uber for freight” company Convoy, the skeletons of startups-past haunt founders and investors alike.

Fidelity marked up Stripe shares by 32% going into 2024

Stripe’s share value jumped in Fidelity’s December report after a tech stocks bull run closed out 2023.

Why Sequoia’s Klarna board drama made the VC world wince

The attempted ousting of legendary ex-Sequoia investor Michael Moritz paints a chaotic picture inside Klarna’s boardroom as it approaches a public listing.

Founders, family offices step up to fill VC fundraising gap

Former founders and wealthy individuals have better access to funds and are making up a bigger share of new VC fund raises, GPs say.

Valuation growth stalls for late-stage startups

The median relative velocity of value creation fell to 14.5% for late-stage startups in 2023, the lowest annual rate since 2016.

Arch Venture Partners targets $3B Fund XIII in most ambitious raise to date

Chicago-based Arch Venture Partners has set ambitious sights for 2024, sending a bullish signal for life sciences and biotech fundraising.

Byju’s equity wipeout could further sour VCs on edtech

Byju’s, one of India’s most prominent startups and once a giant in edtech, is reportedly considering a rights issue that would value the company at 99% below its peak valuation.

IPO Watchlist: The fintech unicorns likely to go public

Klarna’s CEO has said he’s looking at a US public listing “quite soon.” Meanwhile, several homegrown US fintechs have made recent layoffs with an eye to the public markets.

Xerox sunsets CVC, anchors new $200M AI fund instead

Xerox is anchoring a debut AI-focused fund from Myriad Venture Partners, a new firm spun out by Xerox Ventures founder Chris Fisher.

Growth investors’ liquidity crunch drives new secondaries vehicles

Launchbay Capital is raising a $100 million fund specifically designed to buy secondary stakes from growth-stage investors starved for cash returns.

Despite AI boost, unicorn creation hits 6-year low

Fewer unicorns were minted in 2023 than any year since 2017, but among them, generative AI companies dominated.

VC fund closes stretch to 15 months—longest in a decade

Venture investors are taking longer than ever to fundraise from LPs, says the latest PitchBook-NVCA Venture Monitor.

Threat of irrelevance looms over emerging VCs

The cards are stacked against emerging GPs in 2024, which are doing everything they can to stay in their LPs’ good graces.